The first day of the BIO Asia–Taiwan partnering meetings was a resounding success!
Neogenesis Biotech successfully concluded Day 1 at BIO Asia–Taiwan Partnering 2026, showcasing AI Cell Report and precis...
Immune Cell Profiling: Ushering in a New Era of Personalized Precision Medicine
Learn how immune cell profiling analyzes T cells, B cells, NK cells, regulatory T cells, and immune exhaustion markers t...
Neogenesis Biotech Officially Joins INNOPAD TAIPEI
INNOPAD TAIPEI focuses on AI, smart healthcare, digital health, and high-tech innovation. We provide comprehensive start...
Ongoing clinical research collaboration with Taipei Veterans General Hospital continues to advance.
Neogenesis Biotech partners with Taipei Veterans General Hospital to advance clinical research by integrating cellular a...
The Era of Precision Regenerative Medicine: Cell Testing as the Foundation for Personalized Therapy
Regenerative medicine is entering a new era of precision healthcare, where cell analysis has become a vital foundation f...
Neogenesis Biotech Participates in BIO Asia–Taiwan 2026 Partnering to Strengthen Global Collaborations
Neogenesis Biotech joined the BIO Asia–Taiwan 2026 Partnering program to showcase its AI Cell Report, precision cell ana...
The Vital Role of Companion Diagnostics in Cell Therapy
In recent years, cell therapy has emerged as a key frontier in regenerative medicine. However, not every patient is a ca...
How AI is Transforming Precision Cell Analysis: Shaping the Future of Smart Healthcare
Discover how AI integrates with flow cytometry and intelligent analysis to enhance the efficiency of cell data interpret...
Continuous Optimization of the Solid Tumor TIL Testing Workflow
Neogenesis Biotech continuously optimizes TIL (Tumor Immersed Lymphoid) detection processes, integrating multicolor flow...